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aBsTRacT
INTRODUCTION: Indication for breast reduction in a public­
ally funded or an insurance­funded setting depends on the 
severity of the subjective symptoms and on the clinical 
evalu ation. The purpose of this study was to evaluate 
whether Danish surgeons follow a clinical practice recom­
mending a minimum tissue resection weight of 400­500 g 
per breast.
METHODS: Included in the study were a total of 366 female 
patients with breast hypertrophy who underwent bilateral 
breast reduction surgery at three large university hospitals in 
Denmark in the period from August 2008 to November 2013. 
The patients’ height, weight and standard breast measure­
ment were registered as was the weight of breast tissue re­
section. The preoperative breast volume was measured us­
ing transparent plastic cups designed for this purpose.
RESULTS: Among the 366 female participants, the median 
age was 40 years, the median BMI was 24 kg/m2, and the 
median breast volume was 1,050 cc on each side. Only 201 
(55%) cases met the resection criterion of a minimum of 
400 g tissue per breast, and 130 (36%) had 500 g or more 
resected. We found a highly significant correlation between 
the amount of resected breast tissue and the preoperative 
breast volume (p < 0.001, n = 366).
CONCLUSIONS: Many surgeons did not follow the clinical 
practice of resecting 400­500 g of breast tissue in women 
who underwent breast reduction surgery at three large hos­
pitals in Denmark in the 2008­2013 period. Our findings are 
surprising and beg the question if the guidelines should be 
revised to reflect the current practice or vice versa.
FUNDING: none.
TRIAL REGISTRATION: not relevant.
Breast reduction surgery is a common and successful 
surgical treatment for shoulder/neck pain, bra­strap 
grooving, back pain and headache due to breast hyper­
trophy [1, 2]. Several studies have also shown improved 
quality of life and improvement in psychosocial symp­
toms after breast reduction surgery [3, 4]. To be oper­
ated in a publicly financed healthcare system such as 
those of the Scandinavian countries, patients seeking 
breast reduction must present with adequate functional 
problems and not only with cosmetic concerns [5]. To 
distinguish cases that are based primarily on cosmetic 
complaints from those based on functional complaints, a 
woman requesting breast reduction surgery in Denmark 
must, as in most other countries, express relevant phys­
ical symptoms, preferably be 18 years of age or more, 
and shall generally have a body mass index (BMI) below 
25 kg/m2.  According to standard clinical practice, the 
breast volume must be of a size that allows resection of 
at least 400­500 g on each side. [5­8]. This is based not 
on a national guideline, but on local clinical practices [7, 
8], which are quite similar over the country (exceptions 
from these demands are occasionally allowed; for in­
stance, if the woman has co­morbidity, short stature, 
ser ious gigantomastia, etc.)  Furthermore, to some ex­
tent the following measurements may also be used for 
evaluation: sternal notch­to­nipple distance (NND), pto­
sis (distance from the lower pole of the breast to the 
sub­mammary fold) and chest circumference. In a previ­
ous study [5], we evaluated the feasibility of measuring 
preoperative breast volume using special plastic cups, 
and the pre­operative volume was correlated to the de­
cision of offering breast reduction surgery. This previous 
study was undertaken in recognition of the need for a 
more objective criterion for the decision to perform 
breast reduction surgery. In three departments of plastic 
surgery in Eastern Denmark, we found full agreement 
that, in general, women with relevant complaints who 
fulfilled the inclusion criteria were offered reduction sur­
gery if they had a breast volume of 900 cc or more, 
while women with a breast volume of less than 800 cc 
were denied surgery [5]. The aim of the present study 
was to evaluate whether surgeons actually comply with 
the clinical practice [7, 8] stipulating a minimum tissue 
resection weight of 400­500 g per breast.
mEThOds
data collection
For the present study, we searched the electronic sur­
gical database for patients registered with the diagnosis 
breast hypertrophy (N62.9) and the procedure code 
breast reduction (KHAD30 and KHAD35) according to 
coding system of the International Classification of Dis­
eases, 10th Edition (ICD­10). The search was done in No­
vember 2013 and included all patients operated be­
tween January 2008 and November 2013 at one of the 
three plastic surgery departments at the Copenhagen 
University Hospitals (Herlev Hospital, Roskilde Hospital, 
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and Rigshospitalet, Denmark). A total of 674 patients 
were identified. Patients were excluded from this study 
if information about the weight of the resected breast 
tissue was missing, if surgery was done because of 
breast cancer or asymmetric breasts, if the patient had a 
history of previous breast surgery, was of male gender, 
or had undergone massive weight loss (> 15 BMI points) 
causing excessive skin since breast operation in that 
scen ario generally was performed on a different indica­
tion (breast lift rather than breast reduction). 
We recorded the following parameters from elec­
tronic and paper­based patient records: age (years), 
weight (kg), height (cm), BMI (kg/m2), chest circumfer­
ence (cm), sternal NND distance (cm), the degree of pto­
sis (cm) measured as the distance from the infra­mam­
mary fold to the lower pole of the breast, weight of 
resected breast tissue (g) and the preoperative breast 
volume (cc).
The preoperative breast volume was measured by 
the surgeon who used transparent plastic cups with 
eleven different sizes: 200, 275, 350, 500, 650, 850, 950, 
1,150, 1,350, 1,600 and 2,000 cc. If the measured vol­
ume fell between two cup sizes, the surgeon made a 
best estimate (below 750 cc, the estimate was made at 
25 cc intervals; above it was made at 50 cc intervals) [5]. 
The other parameters were measured with a ruler and a 
weight scale at the preoperative examination.
The decision to operate was made by the examining 
specialised plastic surgeon. In cases in which the exam­
ining surgeon was in training or if the specialised sur­
geon needed to confer the case, the decision was 
cleared with a senior colleague or in conference with 
more colleagues. 
The decision was made according to the existing cri­
teria: hypertrophic breasts, relevant functional com­
plaints, normal body weight, a need/possibil ity to excise 
more than 400­500 g of tissue per breast; in the later 
part of the period (2012­2013), a breast volume of 900 
cc or more influenced the decision in favour of surgery, 
provided that the other criteria were met. The weight of 
the resected breast tissue was found in the patient 
charts.
This study did not need ethical approval from the 
local ethical committee.
statistical analysis
The primary endpoint was to establish whether the sur­
geons followed clinical practice [7, 8] by resecting a min­
imum of either 400 or 500 g of breast tissue per breast 
in patients suffering from breast hypertrophy (both 
scen arios were tested). Our secondary endpoint was to 
evaluate if there was a correlation between the demo­
graphic variables:  patient’s age, breast volume, sternal 
NND, breast ptosis, height, weight, BMI and the weight 
of the resected breast tissue.
Simple demographic data are presented in fre­
quency tables as medians and ranges. A test to examine 
if data were normally distributed was performed (the 
Shapiro­Wilk test); only height and weight followed a 
normal distribution; all other parameters did not (p < 
0.001). Side­to­side measures were compared using the 
non­parametric two­independent samples test, as data 
were not normally distributed.
The Kruskal­Wallis test was performed to examine a 
possible difference between the three centres in terms 
of: 1) meeting the resection criteria and 2) difference in 
preoperative breast volume and resected breast tissue 
weight. 
We used binary logistic regression analysis to deter­
mine if there was an association between resected 
breast tissue and one or more of the variables men­
tioned above. In addition, correlation analysis for every 
possible significant covariate and resected tissue weight 
was undertaken using SPSS Statistics 20 for Mac to de­
termine Spearman’s correlation coefficient.
Trial registration: not relevant.
TaBlE 1
Demographic variables among the 366 study women undergoing breast 
reduction surgery.
median (range) na
Age, yrs 40 (15­80) 366
Height, cm 166 (145­183) 364
Weight, kg 66 (48­86) 364
Body mass index, kg/m2 24 (17.8­31.8) 364
Breast volume, cc
Right 1,050 (500­5,500) 362
Left 1,050 (500­3,300) 362
Average 1,050 (500­4,400) 362
Sternal notch-to-nipple distance, cm
Right 29 (18­48) 366
Left 29 (18­43) 366
Average 29 (18­46) 366
Breast ptosisb, cm
Right­sided 7 (1­21) 361
Left­sided 7 (2­20) 361
Average 7 (2­20) 361
Breast tissue resection, g
Right 459 (100­2,420) 366
Left 460 (100­3,570) 366
Average 463 (100­2,995) 366
Difference in volume in the 2 breasts, cc  50 (0­2,200) 362
Difference in tissue resection in the  
2 breasts, g
54 (0­1,150) 366
a) Number of study women for whom the variable in question is known.
b) Ptosis is present if the lower breast pole is below the infra­mammary 
fold (IMF) and measured in cm from the IMF to the lower breast pole.
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REsUlTs
We identified 674 patients who underwent breast re­
duction surgery at Herlev Hospital (n = 150), Roskilde 
Hospital (n = 382) and Rigshospitalet (n = 142) in the  
period from January 2008 to November 2013. In total, 
we excluded 308 patients because they were found to 
have undergone breast reduction due to contralateral 
breast cancer (symmetrisation/weight reduction), asym­
metric breasts, earlier gastric by­pass or male gynaeco­
mastia; and in one case, the weight of the resected 
breast tissue was missing. Thus, a total of 366 women 
who underwent bilateral breast reduction surgery due 
to breast hypertrophy were included in the study.
The median age of the patients was 40 (range: 15­
80) years. The median BMI was 24 (range: 17.8­31.8)  
kg/m2. A total of 29 patients had a BMI of 26 kg/m2 or 
above. There was no difference between the right­ and 
left­sided breast volume (p = 0.896) or resection tissue 
weight between the two sides (p = 0.662). We therefore 
used the average value of the right and left sides for all 
bilateral analyses. The median preoperative breast vol­
ume was measured to 1,050 cc (range: 500­4,400 cc).  
A total of five patients had a very low breast volume, be­
low 700 cc, and these patients were among the shortest 
in the study population. The median weight of breast tis­
sue resection was 463 g (range: 101­2,995 g).
The clinical practice [7, 8] stipulating that at least 
400 g breast tissue has to be removed per breast was 
met in 201 out of 366 cases (55%), but was not met in 
the remaining 165 cases (45%). The criterion that at 
least 500 g breast tissue has to be removed per breast 
was met in 130 out of the 366 (36%) cases; hence, this 
criterion was not met in 236 cases (64%). We evaluated 
if the number of operations and meeting of the weight 
criterion differed substantially over the years. Variations 
were found, but none pointed at a distinct pattern  
(data not shown). Additional clinical data are shown in 
Table 1.
Binary logistic regression analysis using the 400­g­
criterion as the dependent variable and age, breast vol­
ume, sternal NND, ptosis, height, weight, and BMI as  
covariates showed that breast volume was the only sig­
nificant covariate (p < 0.001). Using the 500­g­criterion, 
we found the breast volume (p < 0.001) and the sternal 
NND (p = 0.016) to be significant covariates. 
We found a strong correlation between breast vol­
ume and weight of resected breast tissue (p < 0.001) 
(Figure 1). The correlation between the weight of the re­
sected breast tissue and sternal NND was also statistic­
ally significant (p < 0.001) (Figure 2). 
There was no significant difference in preoperative 
breast volume (p = 0.122) and the weight of resected 
the breast tissue between the three centres (p = 0.892) 
(Figure 3 and Figure 4).
discUssiOn
In the present study, we investigated to which extent 
clinical practice [7, 8] regarding breast reduction surgery 
was followed at three large hospitals in Denmark. At 
present, a national guideline has yet to be prepared, but 
all Danish departments have a rule of thumb that a min­
imum of 400 g (some departments) or 500 g (other de­
partments) of breast tissue should be resected in order 
to justify the need/indication for breast reduction in a 
public setting. This is in line with most international 
guidelines [9]. The background for this very specific re­
FigURE 1
Correlation between breast resection and pre­operative breast volume. Scatter plot demonstrating cor­
relation of pre­operative average breast volume with average resection weight (R2 = 0.696).
3,500


















Correlation between breast resection and sternal notch­to­nipple distance. Scatter plot demonstrating 










0 10 20 30 40 50
Resection, g
Distance, cm
 4   da n i s h m E d i c a l J O U R n a l Dan Med J 62/1   January 2016
quirement remains somewhat obscure, but it presum­
ably originates from the insurance­funded sector where 
an objective criterion for reimbursement has been de­
manded [9]. The main finding of the present study in­
cluding 366 women who were operated between 2008 
and 2013 was that the resection weight criterion was 
met only in 36­55% of cases, depending on whether the 
500 g or the 400 g criterion was used. The amount of re­
sected tissue was significantly associated with the pre­
operative breast volume. However, breast density is not 
always 1 kg/l. A recent study showed that breast volume 
calculated from magnetic resonance imaging corres­
ponds well with the subsequent mastectomy specimen 
weight; however, in dense breasts with pronounced fi­
broglandular tissue, the breast volume would be over­
estimated when based on weight information. A math­
ematical model including breast density was developed 
[10]. 
We found a few patients with preoperative breast 
volumes below 700 cc (n = 5, range: 500­688 cc). All 
these women were of short stature or had a preopera­
tive BMI of 26 kg/m2 or higher (n = 29, range: 26.0­31.8). 
These patients should not generally have been approved 
for breast reduction. We can therefore conclude that 
also the general admittance criteria were not always 
met.
The three hospitals that participated in this study 
did not vary significantly with regard to their surgical 
practice, and we therefore believe that the Danish prac­
tice is reflected in this study.
Female symptomatic breast hypertrophy is defined 
as a syndrome of large breast causing persistent muscle 
strain such as neck/shoulder/back pain, headache, bras­
siere­strap grooving and often chronic rash in the in­
framammary fold [1, 2]. In addition, women suffering 
from symptomatic breast hypertrophy report physical 
limitations regarding exercise and activities, as well as a 
gradual change in posture with a trend towards kyph­
osis. Furthermore, several studies have shown improved 
quality of life and improvement in psychological and 
psychosocial symptoms after breast reduction [3, 4]. 
Kerrigan et al reported that 87.6% of females with 
breast hypertrophy have at least two out of seven 
breast­related physical symptoms that occur all or most 
of the time compared with 2% of females with a normal 
breast size (C cup or smaller) [11]. Breast reduction sur­
gery in women with breast hypertrophy has also been 
found to improve quality of life, which includes in­
creased sociability, emotional stability, self­esteem and 
decreased anxiety and depressive symptoms [12, 13].
In the present study, we found that in 45­64% of 
cases, the plastic surgeons in three large hospitals in 
Denmark removed less than the 400­500 g of breast tis­
sue stipulated by clinical practice [7, 8]. There is evi­
dence to support that females with similar preoperative 
breast hypertrophy­related symptoms have similar post­
operative symptom relief after breast reduction, regard­
less of their resection weight [14]. Another study com­
paring females who were covered by insurance (the 
criterion of 500 g of breast tissue removal was met) with 
a control group who was not (criterion of 500 g breast 
tissue removal was not met) reported no difference in 
preoperative symptoms and post­operative improve­
ment in quality of life [11]. In addition, several studies 
have found a strong correlation between breast resec­
tion weight and the risk of complications such as de­
layed wound healing, wound dehiscence, nipple/areola 
necrosis, haematoma, seroma, fat necrosis, hyper­
trophic scarring and infection [1, 15­17]. The preopera­
tive breast volume probably confounds this correlation: 
FigURE 4
Centre­specific distribution of preoperative breast volume and resected breast tissue. The average pre­
operative breast volume and average weight of resected breast tissue for the three centres. We found 
no significant difference in average preoperative breast volume or average resection weight between 
the centres, (p = 0.122) and (p = 0.892) respect ively.
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the larger the breast, the more is resected, as demon­
strated in the present study. Concerning BMI, studies 
show no difference in post­operative complications and 
rates in females with a BMI above 25 compared with fe­
males with a BMI below 25 [1, 15­17]. 
The ideal breast shape has changed throughout his­
tory, going from the Victorian monobosom to the small 
and flat, and to nowadays big and often with an artifi­
cially rounded appearance [18]. It seems that “the nor­
mal breast has become larger” during the last decade. 
Implants used for breast augmentation have increased 
[19], and this may actually explain why we observed a 
lower than required resection of hypertrophic breast tis­
sue in the present study. One study shows “that plastic 
surgeons and patients seeking breast augmentation may 
have drastically different perceptions of what consti­
tutes an attractive, natural and ideal breast shape” [20]. 
By applying his/her own sense of aesthetics to the final 
outcome, the surgeon’s opinion may be a confounding 
variable on the amount of resected breast tissue. On the 
other hand, the patients’ perception of what constitutes 
an ideal breast shape may as well influence the surgeon 
who seeks to satisfy the patient’s perceived need.
cOnclUsiOns
This study concludes that surgeons of three large Danish 
university hospitals do not always remove a minimum of 
400 g of breast tissue on each side in females with 
breast hypertrophy. We should either change our prac­
tice to abide by the clinical practice or create new, real­
istic guidelines. Evidence supports that females with 
symptomatic breast hypertrophy experience symptom 
relief after breast reduction surgery regardless of their 
resection weight [14], which is probably because the lift­
ing included in a normal breast reduction surgery short­
ens the “downhill­vector” predominant both in breast 
ptosis and hypertrophia. This results in less direct weight 
load in the bra, and thereby on the patient’s neck and 
shoulders. However, we speculate that recurrence of 
the ptosis and thus the weight symptoms will occur 
more readily and earlier in small reductions than in big 
reductions if other parameters remain unchanged. In 
any case, we believe that the criteria for breast reduc­
tion should be defined by individual symptomatology 
taking multiple parameters into consideration rather 
than by reference to breast size alone.
The present study has several strength and limita­
tions. Among the limitations is the study’s retrospective 
design which could give rise to bias in data recording, se­
lection and analysis. Besides, confounding variables may 
go unrecognised because of inadequate knowledge of 
how they interrelate with the outcome of interest. 
Several surgeons in the three participating hospitals per­
formed the clinical preoperative breast measurements 
and often did not operate on the patient themselves. 
Inter­observer variability could be present. However, 
there is no reason to believe that such variability be  
systematically skewed among the study participants. 
Among the strengths of the study are the relatively large 
number of participants, the rather even distribution 
among hospitals and the thorough documentation of 
data. Since the resection weight was recorded without 
knowledge of this study, no trend to influence the out­
come was present. There is good reason to assume that 
this study is representative of the breast reduction prac­
tice in Denmark.
We would like our clinical practice to match reality 
and vice versa. In a restrictive setting, arguments could 
be presented for new and stricter guidelines. However, 
in the authors’ opinion, a considerable number of pa­
tients who seek surgery are refused already [5], and – 
compared with other publicly funded procedures – the 
current practice [7, 8] does comply fairly well with the 
practice among similar procedures (operation for gynco­
mastia, skin reduction procedures after massive weight 
loss, etc.) Instead, we suggest that a new and more ap­
propriate national guideline be prepared. 
Such guidelines should take into account other cri­
teria than weight, e.g. health­related quality of life, and 
they should perhaps also use more sophisticated biome­
chanical measurements, taking the predominant “down­
hill­vector” forces in breast ptosis and hypertrophy into 
consider ation.  Further research is needed to clarify 
these issues.
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